NEW RARE BLOG IS OUT NOW! How do you build a European biotech presence from the ground up? For Matthias Hess, it starts with purpose, precision, and the right people. In the latest edition of RARE, Laura Hulley, Principal Consultant at SciPro, speaks with Matthias Hess, Senior Vice President and Head of Europe at SpringWorks Therapeutics, about his transition from big pharma to rare disease leadership, and what it takes to deliver life-changing treatments across complex European markets. With SpringWorks expanding its reach and preparing for multiple EU launches, Matthias shares lessons in strategy, agility, and building with intention. Tune in for insight into: 🏥 Why rare tumors demand a precision-first approach 📍 How Switzerland became the ideal launchpad for growth 💡 What it takes to lead with vision in a fast-moving landscape Head to the our website to read the full blog and watch the episode now: https://lnkd.in/dfvDu5cd #RareTumors #PrecisionMedicine #Biotech
